The study looks at hospitalized patients predominantly in the US along with Spain, China, and South Korea. The roughly 300,000 patients received a combination of 3455 different repurposed and adjunctive drugs.
COVID-19 clinical trials
ACSH relies on donors like you. If you enjoy our work, please contribute.
Make your tax-deductible gift today!
Popular articles
ACSH Podcasts
